OpenVSafe by OpenVAERS
Search V-safe

A5L-16825-45056

3 vaccinations 11 coded responses 16 check-ins 10 free-text entries 3 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
853 / AZ
Registered
2021-01-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-14
    Dose 2 — Pfizer-BioNTech
  3. 2021-01-19
    Registered in v-safe
  4. 2021-01-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Arthralgia, Chills, Diarrhoea, Fatigue, Nausea, Rash — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection site · Be unable to work
    Free text: After the injection I had chills, joint pain, rash, diarrhea, nausea, fatigue,
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-21
    Health check-in — day 7, dose 2
    Feeling: Good · Rash, not including the immediate area around the injection site
    Adult check-in
  6. 2021-01-28
    Survey response — day 14, dose 2
    MedDRA: Tinnitus — Feeling: Good
    Free text: Tinnitus
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-04
    Survey response — day 21, dose 2
    MedDRA: Tinnitus, Vertigo — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Tinnitus, vertigo
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-04
    Report sent to call center — day 21, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-02-11
    Survey response — day 28, dose 2
    MedDRA: Deafness, Pre-existing disease, Tinnitus — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Worsening tinnitus and hearing loss
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-18
    Survey response — day 35, dose 2
    MedDRA: Hyperacusis, Medical counselling, Pre-existing disease, Tinnitus — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Worsening tinnitus and hearing issues · Healthcare visit (other): Curbside. Im a provider.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-18
    Report sent to call center — day 35, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-02-25
    Survey response — day 42, dose 2
    MedDRA: Deafness, Tinnitus — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Tinnitus and hearing loss
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-15
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  14. 2021-06-29
    Call successful
    Participant prefers to complete VAERS report online
  15. 2021-06-29
    Call successful
    Participant prefers to complete VAERS report online
  16. 2022-01-10
    Dose 3 — Pfizer-BioNTech
  17. 2022-01-14
    Survey response — 12 months, dose 2
    MedDRA: Fatigue, Headache, Lymphadenopathy, Nausea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: After Covid vaccine, severe fatigue, supraclavicular lymphadenopathy, some nausea, headache
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-01-14
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy, Tinnitus — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Supraclavicular lymphadenopathy, continued tinnitus
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-01-15
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  20. 2022-01-16
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy, Tinnitus — Feeling: Poor · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Still supraclavicular lymphadenopathy and tinnitus continues
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-01-17
    Survey response — day 7, dose 3
    MedDRA: Tinnitus — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Continuing tinnitus
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-01-26
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  23. 2022-04-13
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  24. 2023-01-10
    Survey response — 12 months, dose 3
    MedDRA: Cough, Dyspnoea, Fatigue, Medical counselling, Oxygen saturation decreased, Wheezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    MedDRA releases: 2024-11
  25. 2023-01-10
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Hospitalization · 1 call case(s)
  26. 2023-01-11
  27. 2023-01-17

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech
22021-01-14Pfizer-BioNTech
32022-01-10Pfizer-BioNTech No

Call center

3 call center cases

2 successful · 1 unsuccessful

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-19

Systemic reaction (other): After the injection I had chills, joint pain, rash, diarrhea, nausea, fatigue,

Release 3 — day 14, dose 2

2021-01-28

Symptoms: Tinnitus

Release 3 — day 21, dose 2

2021-02-04

Symptoms: Tinnitus, vertigo

Release 4 — day 28, dose 2

2021-02-11

Symptoms: Worsening tinnitus and hearing loss

Release 4 — day 35, dose 2

2021-02-18

Symptoms: Worsening tinnitus and hearing issues
Healthcare visit (other): Curbside. Im a provider.

Release 4 — day 42, dose 2

2021-02-25

Symptoms: Tinnitus and hearing loss

Release 10 — 12 months, dose 2

2022-01-14

Symptoms: After Covid vaccine, severe fatigue, supraclavicular lymphadenopathy, some nausea, headache

Release 10 — days 1–6 daily, dose 3

2022-01-14

Systemic reaction (other): Supraclavicular lymphadenopathy, continued tinnitus

2022-01-16

Systemic reaction (other): Still supraclavicular lymphadenopathy and tinnitus continues

Release 10 — day 7, dose 3

2022-01-17

Systemic reaction (other): Continuing tinnitus

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling ✓ ✓ ✓
SDCough · · ✓
SDDeafness ✓ ✓ ✓
SDDyspnoea · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDHyperacusis ✓ ✓ ✓
SDLymphadenopathy · · ✓
SDNausea · · ✓
SDOxygen saturation decreased · · ✓
SDPre-existing disease ✓ ✓ ✓
SDTinnitus ✓ ✓ ✓
SDVertigo ✓ ✓ ✓
SDWheezing · · ✓
SROArthralgia ✓ ✓ ✓
SROChills ✓ ✓ ✓
SRODiarrhoea ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROLymphadenopathy · · ✓
SRONausea ✓ ✓ ✓
SRORash ✓ ✓ ✓
SROTinnitus · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release